Viroinformatics-Based Analysis of SARS-CoV-2 Core Proteins for Potential Therapeutic Targets
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a novel coronavirus for which no known effective antiviral drugs are available. In the present study, to accelerate the discovery of potential drug candidates, bioinformatics-based in silico drug discovery approaches are utilized. We pe...
Main Authors: | Lokesh Agrawal, Thanasis Poullikkas, Scott Eisenhower, Carlo Monsanto, Ranjith Kumar Bakku, Min-Hua Chen, Rajkumar Singh Kalra |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Antibodies |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4468/10/1/3 |
Similar Items
-
Structural insights into SARS-CoV-2 infection and therapeutics development
by: Gangyu Sun, et al.
Published: (2021-04-01) -
Repurposing potential of Ayurvedic medicinal plants derived active principles against SARS-CoV-2 associated target proteins revealed by molecular docking, molecular dynamics and MM-PBSA studies
by: Akalesh Kumar Verma, et al.
Published: (2021-05-01) -
Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico
by: Mitsuru Sada, et al.
Published: (2020-10-01) -
Rilpivirine inhibits SARS-CoV-2 protein targets: A potential multi-target drug
by: Fuad Ameen, et al.
Published: (2021-10-01) -
The potential of Paritaprevir and Emetine as inhibitors of SARS-CoV-2 RdRp
by: Arun Bahadur Gurung, et al.
Published: (2021-02-01)